![Pharmaceuticals | Free Full-Text | The Efficacy of Iron Chelators for Removing Iron from Specific Brain Regions and the Pituitary—Ironing out the Brain Pharmaceuticals | Free Full-Text | The Efficacy of Iron Chelators for Removing Iron from Specific Brain Regions and the Pituitary—Ironing out the Brain](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-12-00138/article_deploy/html/images/pharmaceuticals-12-00138-g001-550.jpg)
Pharmaceuticals | Free Full-Text | The Efficacy of Iron Chelators for Removing Iron from Specific Brain Regions and the Pituitary—Ironing out the Brain
![Chemical structures of iron chelators described in this study: DFO, L1,... | Download Scientific Diagram Chemical structures of iron chelators described in this study: DFO, L1,... | Download Scientific Diagram](https://www.researchgate.net/publication/5427342/figure/fig1/AS:278626277838857@1443441090006/Chemical-structures-of-iron-chelators-described-in-this-study-DFO-L1-ICL670A-PIH-DP.png)
Chemical structures of iron chelators described in this study: DFO, L1,... | Download Scientific Diagram
Synthesis and iron chelating properties of hydroxypyridinone and hydroxypyranone hexadentate ligands - Dalton Transactions (RSC Publishing)
![Figure 2, General iron chelator desferrioxamine (DFO) - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf Figure 2, General iron chelator desferrioxamine (DFO) - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK143197/bin/ml228f2.jpg)
Figure 2, General iron chelator desferrioxamine (DFO) - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
![Natural Iron Chelators as Potential Therapeutic Agents for the Treatment of Iron Overload Diseases | IntechOpen Natural Iron Chelators as Potential Therapeutic Agents for the Treatment of Iron Overload Diseases | IntechOpen](https://cdnintech.com/media/chapter/77500/1512345123/media/F1.png)
Natural Iron Chelators as Potential Therapeutic Agents for the Treatment of Iron Overload Diseases | IntechOpen
![Synthetic and natural iron chelators: therapeutic potential and clinical use | Future Medicinal Chemistry Synthetic and natural iron chelators: therapeutic potential and clinical use | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc.09.121/asset/images/medium/graphic85.gif)
Synthetic and natural iron chelators: therapeutic potential and clinical use | Future Medicinal Chemistry
![The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases | ACS Chemical Biology The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases | ACS Chemical Biology](https://pubs.acs.org/cms/10.1021/acschembio.9b00289/asset/images/medium/cb-2019-00289w_0008.gif)
The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases | ACS Chemical Biology
![Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine - Komoto - 2021 - Cancer Science - Wiley Online Library Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine - Komoto - 2021 - Cancer Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e3289630-30ad-40d8-9a1f-1658ce2099c5/cas14607-fig-0001-m.jpg)
Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine - Komoto - 2021 - Cancer Science - Wiley Online Library
![An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cells | Cancer & Metabolism | Full Text An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cells | Cancer & Metabolism | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40170-022-00284-x/MediaObjects/40170_2022_284_Fig6_HTML.png)
An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cells | Cancer & Metabolism | Full Text
![Frontiers | Novel iron chelator SK4 demonstrates cytotoxicity in a range of tumour derived cell lines Frontiers | Novel iron chelator SK4 demonstrates cytotoxicity in a range of tumour derived cell lines](https://www.frontiersin.org/files/Articles/1005092/fmolb-09-1005092-HTML/image_m/fmolb-09-1005092-g001.jpg)
Frontiers | Novel iron chelator SK4 demonstrates cytotoxicity in a range of tumour derived cell lines
![The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer | Pharmacological Reviews The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer | Pharmacological Reviews](https://pharmrev.aspetjournals.org/content/pharmrev/57/4/547/F2.large.jpg)